Developer docs
API playgroundTry for free, no card

Search company profiles

Sansure

Full company profile

uuid003lmpi

Namestring
Sansure
Legal namestring
Sansure Biotech Inc.
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Sansure Biotech Inc. (founded 2008, headquartered in Changsha, China) is a privately held in vitro diagnostics company specializing in molecular diagnostics based on real-time PCR (polymerase chain reaction) technology. The company has developed a portfolio of over 500 products spanning six major disease areas: respiratory tract infections, reproductive tract infections, blood-borne infections, gastrointestinal infections, vector-borne diseases, and immunoassays. Its platforms rest on six proprietary core technologies — One-Tube Fast Release Technology, Advanced Magnetic Beads Technology, Fully-Automatic Unified Sample Processing Technology, Multiplex Fluorescent PCR-Amplification Technology, mPOCT (mobile point-of-care testing), and Immunological Technology — which collectively reduce nucleic acid testing time from 5-6 hours to under 30 minutes and enable decentralized testing in resource-limited settings.

The company's commercial offering consists of three integrated layers: (1) automated nucleic acid extraction systems (Natch CS2, Natch CS3 Plus, Natch 48, Natch 16S) using advanced magnetic beads for high-purity sample processing; (2) the iPonatic III portable molecular workstation providing 15-45 minute sample-in-result-out point-of-care testing; and (3) an extensive reagent portfolio covering HPV genotyping (13+2, 15HR, G23, 16/18, 6/11), infectious disease panels (SARS-CoV-2/Flu/RSV, monkeypox, six respiratory pathogens), blood safety screening (HBV/HCV/HIV with CE List A certification), and reproductive tract infections. Sansure operates a B2B sales-led model with direct sales to hospitals, clinical laboratories, blood banks, and government health agencies, augmented by seven wholly-owned subsidiaries (Hongan, Accucise, Hygene, QuantuMDx, inno-train, First Light, Sepset) covering different diagnostic verticals and geographies, plus international distribution partnerships and UNICEF-led public health initiatives in Mongolia, Malaysia, and Sierra Leone. Revenue is generated through one-time sales of reagent kits, hardware sales of instruments and mPOCT devices, and through the recurring consumables revenue that follows the installed instrument base.

Short descriptiontext

Sansure is a privately held molecular diagnostics company developing PCR-based in vitro diagnostic products for infectious diseases, HPV screening, blood safety, and respiratory pathogens. It serves hospitals, laboratories, blood banks, and public health agencies globally through seven subsidiary companies and direct distribution.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersChangshan, China
HQ citystring
Changshan
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular diagnostics, in vitro diagnostics, PCR reagents, nucleic acid testing, point-of-care testing
Industry2 codes
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Laboratory Analytical Instruments3826
Product category
In Vitro Diagnostics
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Diagnostic Reagents
TypeOne Time License
Description

Sale of molecular diagnostic reagent kits for infectious disease detection including HPV, HCV, HBV, HIV, respiratory pathogens, and reproductive tract infections. These are consumable products used with the company's instruments.

sansureglobal.com
2Diagnostic Instruments
TypeHardware Sales
Description

Sale and distribution of automated nucleic acid extraction systems (Natch CS2, Natch 48, Natch 16S) and PCR instruments. Instruments provide recurring instrument maintenance and consumables revenue.

sansureglobal.com
3mPOCT Products
TypeHardware Sales
Description

Portable molecular workstation (iPonatic III) and associated test kits sold for point-of-care testing in decentralized settings, clinics, and resource-limited environments.

sansureglobal.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1iPonatic
Description

Portable Molecular Workstation - mPOCT point-of-care testing device for rapid molecular diagnostics

sansureglobal.com
+2 more records
Core offering1 text field

Sansure manufactures and sells molecular diagnostic instruments and reagent kits built on PCR and nucleic acid extraction technologies. Its product ecosystem spans automated extraction systems (Natch CS2, Natch CS3 Plus, Natch 48, Natch 16S), the portable iPonatic point-of-care molecular workstation, and a portfolio of 500+ reagent kits for HPV, HBV, HCV, HIV, respiratory pathogens, monkeypox, and reproductive tract infections. Customers are clinical laboratories, hospitals, blood banks, and public health agencies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Sansure is an in vitro diagnostics company offering a comprehensive molecular diagnostics portfolio centered on real-time PCR technology. The product ecosystem consists of three core pillars: (1) Automated nucleic acid extraction systems (Natch CS2, Natch CS3 Plus, Natch 48, Natch 16S) that use advanced magnetic beads technology for high-purity sample processing; (2) The iPonatic portable molecular workstation series providing point-of-care rapid testing with sample-in-result-out automation in 15-45 minutes; and (3) An extensive reagent portfolio including HPV genotyping kits (S3057E 13+2, S3360E 15HR, S3108E G23, S3019E 16/18, S3017E 6/11), infectious disease panels (SARS-CoV-2/Flu/RSV, Monkeypox, Six Respiratory Pathogens), blood safety screening (HBV/HCV/HIV C004E), and reproductive tract infection tests (CT/UU/NG). The company also provides enabling technology platforms including One-Tube Fast Release Technology, Advanced Magnetic Beads Technology, and Fully-Automatic Unified Sample Processing Technology. All products are designed for compatibility with standard PCR instruments including ABI 7500, QuantStudio 5, and SLAN-96P systems.

Product and service17 records
1iPonatic III Portable Molecular Workstation
CategoryDiagnostic Instrument
Description

Point-of-care molecular diagnostic device offering fully automated rapid testing with 'sample-in-result-out' capability for clinical laboratories, hospitals, clinics, and resource-limited settings. Delivers results in 15-45 minutes using pre-packaged reagents.

2Natch CS2 Fully Automated Nucleic Acid Extraction System
CategoryDiagnostic Instrument
Description

Automated nucleic acid extraction system featuring 3-D magnetic adhesion technology with 117 magnetic racks, anti-contamination design with UV decontamination, and LIS compatibility for laboratory integration. Designed for clinical and hospital laboratories.

3Natch CS3 Plus Fully Automated MDx System
CategoryDiagnostic Instrument
Description

Fully integrated molecular diagnostics system combining sample processing, nucleic acid extraction, and detection capabilities in one platform for clinical laboratories.

4Natch 16S Nucleic Acid Extraction System
CategoryDiagnostic Instrument
Description

Compact nucleic acid extraction device with 1-16 sample throughput, 10 mixing modes, UV lamp and air filtration for anti-contamination. Features 7-inch touch display with user-friendly interface for smaller laboratories.

5Natch 48 Nucleic Acid Extraction System
CategoryDiagnostic Instrument
Description

Automated nucleic acid extraction system designed for medium-to-high throughput laboratories using advanced magnetic beads technology.

6HPV PCR Test Portfolio
CategoryDiagnostic Reagent
Description

Portfolio of Human Papillomavirus DNA diagnostic kits detecting multiple high-risk and low-risk HPV genotypes (including types 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) for cervical cancer screening and HPV genotyping. Used by hospitals and screening programs aligned with WHO cervical cancer elimination strategy.

7Nucleic Acid Test Kit for HBV, HCV, HIV (Type 1+2) (C004E)
CategoryDiagnostic Reagent
Description

Blood donor screening kit for nucleic acid qualitative detection of HBV DNA, HCV RNA, HIV-1 RNA, and HIV-2 RNA in pooled or individual samples. CE List A certified. Designed for blood banks and transfusion centers.

8HIV-1 RNA Quantitative Fluorescence Diagnostic Kit (S3046E)
CategoryDiagnostic Reagent
Description

Quantitative detection of HIV-1 virus RNA in human EDTA plasma with sensitivity of 25 IU/mL for clinical monitoring of HIV patients. CE-certified.

9HCV RNA Detection Kit (HCV Ultra)
CategoryDiagnostic Reagent
Description

Hepatitis C virus RNA detection reagents with qualitative sensitivity of 10 IU/mL and quantitative sensitivity of 12 IU/mL for HCV screening and treatment monitoring in clinical settings.

10HBV DNA Quantitative Diagnostic Kit (HBV Ultra)
CategoryDiagnostic Reagent
Description

Hepatitis B virus DNA quantitative fluorescence diagnostic kit for quantification of HBV DNA in human serum using advanced magnetic beads technology. Used by hospitals and clinical laboratories.

11SARS-CoV-2/Flu/RSV Combination Kit (S3148E)
CategoryDiagnostic Reagent
Description

Multiplex nucleic acid kit for simultaneous detection and differentiation of SARS-CoV-2, influenza, and RSV. Provides results in 36 minutes when paired with iPonatic for clinical and point-of-care use.

12Six Respiratory Pathogens Multiplex Nucleic Acid Diagnostic Kit (S3310E)
CategoryDiagnostic Reagent
Description

Multiplex PCR kit detecting six respiratory pathogens including Legionella pneumophila and Haemophilus influenzae with sensitivity of 340 CFU/ml for clinical infectious disease diagnostics.

13S3352E MPXV Monkeypox Virus Nucleic Acid Diagnostic Kit
CategoryDiagnostic Reagent
Description

Monkeypox virus nucleic acid diagnostic kit with sensitivity of 200 copies/ml using one-tube fast-release technology. Test time less than 30 minutes.

14CT/UU/NG DNA Diagnostic Kit (S3050E)
CategoryDiagnostic Reagent
Description

Simultaneous detection kit for Chlamydia trachomatis, Neisseria gonorrhoeae, and Ureaplasma urealyticum using real-time fluorescence quantitative PCR for early RTI diagnosis in clinical and reproductive health settings.

15Herpes Simplex Virus Type 2 DNA Diagnostic Kit (S3002E)
CategoryDiagnostic Reagent
Description

DNA fluorescence diagnostic kit for detection of HSV-2 DNA in samples for early diagnosis of herpes infection in clinical and reproductive health settings.

16Respiratory Adenovirus DNA Diagnostic Kit
CategoryDiagnostic Reagent
Description

DNA diagnostic kit for detection of respiratory adenovirus with lowest limit of detection of 200 copies/ml. Compatible with common PCR instruments including ABI 7500, QuantStudio 5, and SLAN-96P systems.

17DNA/RNA Extraction Reagents
CategoryDiagnostic Reagent
Description

Sample preparation reagents for extraction and purification of DNA and RNA from various clinical specimens for molecular diagnostics workflows.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-11
Description

Strategic partnership to safeguard maternal and child health in Mongolia. Sansure collaborates with UNICEF Mongolia on public health initiatives, providing diagnostic solutions and support for health programs targeting maternal and child health outcomes.

2Hongan
Strategic tierCoreTypeOthers
Description

Subsidiary company of Sansure focused on specific diagnostic solutions, operating under the Sansure group corporate structure.

sansureglobal.com
Strategic tierCoreTypeOthers
Description

Subsidiary company of Sansure, operating as part of the Sansure group of companies to expand diagnostic product offerings and market reach.

4Hygene
Strategic tierCoreTypeOthers
Description

Subsidiary company of Sansure focused on hygiene and diagnostics-related products, part of the Sansure corporate ecosystem.

sansureglobal.com
Strategic tierCoreTypeOthers
Description

Subsidiary company of Sansure operating within the Sansure group, contributing to the collective diagnostic portfolio.

Strategic tierCoreTypeOthers
Description

Subsidiary company of Sansure, part of the Sansure group network of diagnostic companies.

Strategic tierCoreTypeOthers
Description

Subsidiary company of Sansure operating as part of the Sansure group, focused on specific diagnostic applications.

Strategic tierCoreTypeOthers
Description

Subsidiary company of Sansure included in the Sansure group of companies for expanded diagnostic capabilities.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor in women's health molecular diagnostics, including HPV testing (Aptima) and Panther automated systems. Hologic's high-throughput HPV screening reagents compete directly with Sansure's HPV 13+2, 15HR, and G23 genotyping kits.

TypeDirect peer
Description

Chinese IVD company with strong nucleic acid test (NAT) portfolio for HBV, HCV, HIV blood screening, and HPV. Daan Gene is a direct Chinese competitor in blood safety screening and HPV, the same core categories as Sansure.

TypeDirect peer
Description

Direct peer in nucleic acid extraction and sample preparation technologies (QIAcube, QIAsymphony), plus molecular diagnostic kits for HPV and infectious diseases. Qiagen's magnetic-bead extraction technology directly competes with Sansure's Advanced Magnetic Beads platform.

TypeDirect peer
Description

Chinese-domestic IVD company with overlapping products in chemiluminescence immunoassays, microbiology, and molecular diagnostics. Autobio is the most direct Chinese-listed competitor to Sansure's broader diagnostics portfolio.

TypeBroad incumbent
Description

Broad incumbent in molecular diagnostics with cobas systems and a comprehensive infectious disease, HPV, and blood screening menu. Roche's entrenched installed base in hospital labs sets the competitive benchmark Sansure seeks to disrupt.

6Abbott Molecular
TypeBroad incumbent
Description

Broad incumbent with m2000 and Alinity m systems for molecular diagnostics, covering HPV, HIV, HCV, and HBV. Abbott's global blood bank and clinical lab presence competes with Sansure's C004E blood screening kit and infectious disease portfolio.

TypeBroad incumbent
Description

Broad incumbent with the BioFire FilmArray syndromic PCR panels for respiratory, gastrointestinal, and bloodstream infections. BioFire's point-of-care syndromic testing model overlaps with Sansure's iPonatic mPOCT strategy in decentralized settings.

TypeDirect peer
Description

Direct competitor in multiplex PCR-based molecular diagnostics, particularly for syndromic infectious disease panels. Seegene's Allplex assays compete with Sansure's multiplex respiratory pathogen and CT/UU/NG reproductive infection kits.

9Snibe Diagnostics
TypeDirect peer
Description

Shenzhen-headquartered IVD company with chemiluminescence immunoassay and molecular diagnostic products. Snibe is a comparable Chinese IVD peer with international expansion (CE-marked, exported globally) overlapping Sansure's strategy.

TypeDirect peer
Description

Direct competitor in PCR-based molecular diagnostics, particularly the GeneXpert system for point-of-care and clinical lab nucleic acid testing. Cepheid's cartridge-based PCR platform competes directly with Sansure's iPonatic mPOCT station and Natch extraction systems.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sansure

In Vitro Diagnosticssansureglobal.com

Sansure is a privately held molecular diagnostics company developing PCR-based in vitro diagnostic products for infectious diseases, HPV screening, blood safety, and respiratory pathogens. It serves hospitals, laboratories, blood banks, and public health agencies globally through seven subsidiary companies and direct distribution.

What Sansure does

Sansure Biotech Inc. (founded 2008, headquartered in Changsha, China) is a privately held in vitro diagnostics company specializing in molecular diagnostics based on real-time PCR (polymerase chain reaction) technology. The company has developed a portfolio of over 500 products spanning six major disease areas: respiratory tract infections, reproductive tract infections, blood-borne infections, gastrointestinal infections, vector-borne diseases, and immunoassays. Its platforms rest on six proprietary core technologies — One-Tube Fast Release Technology, Advanced Magnetic Beads Technology, Fully-Automatic Unified Sample Processing Technology, Multiplex Fluorescent PCR-Amplification Technology, mPOCT (mobile point-of-care testing), and Immunological Technology — which collectively reduce nucleic acid testing time from 5-6 hours to under 30 minutes and enable decentralized testing in resource-limited settings.

The company's commercial offering consists of three integrated layers: (1) automated nucleic acid extraction systems (Natch CS2, Natch CS3 Plus, Natch 48, Natch 16S) using advanced magnetic beads for high-purity sample processing; (2) the iPonatic III portable molecular workstation providing 15-45 minute sample-in-result-out point-of-care testing; and (3) an extensive reagent portfolio covering HPV genotyping (13+2, 15HR, G23, 16/18, 6/11), infectious disease panels (SARS-CoV-2/Flu/RSV, monkeypox, six respiratory pathogens), blood safety screening (HBV/HCV/HIV with CE List A certification), and reproductive tract infections. Sansure operates a B2B sales-led model with direct sales to hospitals, clinical laboratories, blood banks, and government health agencies, augmented by seven wholly-owned subsidiaries (Hongan, Accucise, Hygene, QuantuMDx, inno-train, First Light, Sepset) covering different diagnostic verticals and geographies, plus international distribution partnerships and UNICEF-led public health initiatives in Mongolia, Malaysia, and Sierra Leone. Revenue is generated through one-time sales of reagent kits, hardware sales of instruments and mPOCT devices, and through the recurring consumables revenue that follows the installed instrument base.

Sansure firmographics

Firmographics
Name
Sansure
Legal name
Sansure Biotech Inc.
Website
https://sansureglobal.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Sansure is a privately held molecular diagnostics company developing PCR-based in vitro diagnostic products for infectious diseases, HPV screening, blood safety, and respiratory pathogens. It serves hospitals, laboratories, blood banks, and public health agencies globally through seven subsidiary companies and direct distribution.
Ownership category
akta.pro rank

Sansure industry classification

Industry
Product category
In Vitro Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAI
Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes)
SECONDARYHLAGAEAI
Sample Logistics, Biorepository & IVD Kit Management (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Molecular diagnostics
  • In vitro diagnostics
  • PCR reagents
  • Nucleic acid testing
  • Point-of-care testing

Where Sansure is headquartered

Location

Headquarters

HQ city
Changshan
HQ country
China
HQ region
Asia

Offices1 record

Markets served

Sansure business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Diagnostic Reagents: Sale of molecular diagnostic reagent kits for infectious disease detection including HPV, HCV, HBV, HIV, respiratory pathogens, and reproductive tract infections. These are consumable products used with the company's instruments.
  2. Diagnostic Instruments: Sale and distribution of automated nucleic acid extraction systems (Natch CS2, Natch 48, Natch 16S) and PCR instruments. Instruments provide recurring instrument maintenance and consumables revenue.
  3. mPOCT Products: Portable molecular workstation (iPonatic III) and associated test kits sold for point-of-care testing in decentralized settings, clinics, and resource-limited environments.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Sansure product offering

Product offering

Core offering

Sansure manufactures and sells molecular diagnostic instruments and reagent kits built on PCR and nucleic acid extraction technologies. Its product ecosystem spans automated extraction systems (Natch CS2, Natch CS3 Plus, Natch 48, Natch 16S), the portable iPonatic point-of-care molecular workstation, and a portfolio of 500+ reagent kits for HPV, HBV, HCV, HIV, respiratory pathogens, monkeypox, and reproductive tract infections. Customers are clinical laboratories, hospitals, blood banks, and public health agencies.

Product overview

Sansure is an in vitro diagnostics company offering a comprehensive molecular diagnostics portfolio centered on real-time PCR technology. The product ecosystem consists of three core pillars: (1) Automated nucleic acid extraction systems (Natch CS2, Natch CS3 Plus, Natch 48, Natch 16S) that use advanced magnetic beads technology for high-purity sample processing; (2) The iPonatic portable molecular workstation series providing point-of-care rapid testing with sample-in-result-out automation in 15-45 minutes; and (3) An extensive reagent portfolio including HPV genotyping kits (S3057E 13+2, S3360E 15HR, S3108E G23, S3019E 16/18, S3017E 6/11), infectious disease panels (SARS-CoV-2/Flu/RSV, Monkeypox, Six Respiratory Pathogens), blood safety screening (HBV/HCV/HIV C004E), and reproductive tract infection tests (CT/UU/NG). The company also provides enabling technology platforms including One-Tube Fast Release Technology, Advanced Magnetic Beads Technology, and Fully-Automatic Unified Sample Processing Technology. All products are designed for compatibility with standard PCR instruments including ABI 7500, QuantStudio 5, and SLAN-96P systems.

Differentiator

Problem solved

Functional benefit

Brands

  • iPonatic: Portable Molecular Workstation - mPOCT point-of-care testing device for rapid molecular diagnostics
  • Natch
  • Sansure eDoc

Products and services

  • iPonatic III Portable Molecular Workstation Point-of-care molecular diagnostic device offering fully automated rapid testing with 'sample-in-result-out' capability for clinical laboratories, hospitals, clinics, and resource-limited settings. Delivers results in 15-45 minutes using pre-packaged reagents.
  • Natch CS2 Fully Automated Nucleic Acid Extraction System Automated nucleic acid extraction system featuring 3-D magnetic adhesion technology with 117 magnetic racks, anti-contamination design with UV decontamination, and LIS compatibility for laboratory integration. Designed for clinical and hospital laboratories.
  • Natch CS3 Plus Fully Automated MDx System Fully integrated molecular diagnostics system combining sample processing, nucleic acid extraction, and detection capabilities in one platform for clinical laboratories.
  • Natch 16S Nucleic Acid Extraction System Compact nucleic acid extraction device with 1-16 sample throughput, 10 mixing modes, UV lamp and air filtration for anti-contamination. Features 7-inch touch display with user-friendly interface for smaller laboratories.
  • Natch 48 Nucleic Acid Extraction System Automated nucleic acid extraction system designed for medium-to-high throughput laboratories using advanced magnetic beads technology.
  • HPV PCR Test Portfolio Portfolio of Human Papillomavirus DNA diagnostic kits detecting multiple high-risk and low-risk HPV genotypes (including types 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) for cervical cancer screening and HPV genotyping. Used by hospitals and screening programs aligned with WHO cervical cancer elimination strategy.
  • Nucleic Acid Test Kit for HBV, HCV, HIV (Type 1+2) (C004E) Blood donor screening kit for nucleic acid qualitative detection of HBV DNA, HCV RNA, HIV-1 RNA, and HIV-2 RNA in pooled or individual samples. CE List A certified. Designed for blood banks and transfusion centers.
  • HIV-1 RNA Quantitative Fluorescence Diagnostic Kit (S3046E) Quantitative detection of HIV-1 virus RNA in human EDTA plasma with sensitivity of 25 IU/mL for clinical monitoring of HIV patients. CE-certified.
  • HCV RNA Detection Kit (HCV Ultra) Hepatitis C virus RNA detection reagents with qualitative sensitivity of 10 IU/mL and quantitative sensitivity of 12 IU/mL for HCV screening and treatment monitoring in clinical settings.
  • HBV DNA Quantitative Diagnostic Kit (HBV Ultra) Hepatitis B virus DNA quantitative fluorescence diagnostic kit for quantification of HBV DNA in human serum using advanced magnetic beads technology. Used by hospitals and clinical laboratories.
  • SARS-CoV-2/Flu/RSV Combination Kit (S3148E) Multiplex nucleic acid kit for simultaneous detection and differentiation of SARS-CoV-2, influenza, and RSV. Provides results in 36 minutes when paired with iPonatic for clinical and point-of-care use.
  • Six Respiratory Pathogens Multiplex Nucleic Acid Diagnostic Kit (S3310E) Multiplex PCR kit detecting six respiratory pathogens including Legionella pneumophila and Haemophilus influenzae with sensitivity of 340 CFU/ml for clinical infectious disease diagnostics.
  • S3352E MPXV Monkeypox Virus Nucleic Acid Diagnostic Kit Monkeypox virus nucleic acid diagnostic kit with sensitivity of 200 copies/ml using one-tube fast-release technology. Test time less than 30 minutes.
  • CT/UU/NG DNA Diagnostic Kit (S3050E) Simultaneous detection kit for Chlamydia trachomatis, Neisseria gonorrhoeae, and Ureaplasma urealyticum using real-time fluorescence quantitative PCR for early RTI diagnosis in clinical and reproductive health settings.
  • Herpes Simplex Virus Type 2 DNA Diagnostic Kit (S3002E) DNA fluorescence diagnostic kit for detection of HSV-2 DNA in samples for early diagnosis of herpes infection in clinical and reproductive health settings.
  • Respiratory Adenovirus DNA Diagnostic Kit DNA diagnostic kit for detection of respiratory adenovirus with lowest limit of detection of 200 copies/ml. Compatible with common PCR instruments including ABI 7500, QuantStudio 5, and SLAN-96P systems.
  • DNA/RNA Extraction Reagents Sample preparation reagents for extraction and purification of DNA and RNA from various clinical specimens for molecular diagnostics workflows.

Companies that use Sansure

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Sansure technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature6 records

Sansure partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • UNICEF MongoliacoreStrategic or Co-development Partner · 11 December 2025Strategic partnership to safeguard maternal and child health in Mongolia. Sansure collaborates with UNICEF Mongolia on public health initiatives, providing diagnostic solutions and support for health programs targeting maternal and child health outcomes.
  • HongancoreOthersSubsidiary company of Sansure focused on specific diagnostic solutions, operating under the Sansure group corporate structure.
  • AccucisecoreOthersSubsidiary company of Sansure, operating as part of the Sansure group of companies to expand diagnostic product offerings and market reach.
  • HygenecoreOthersSubsidiary company of Sansure focused on hygiene and diagnostics-related products, part of the Sansure corporate ecosystem.
  • QuantuMDxcoreOthersSubsidiary company of Sansure operating within the Sansure group, contributing to the collective diagnostic portfolio.
  • inno-traincoreOthersSubsidiary company of Sansure, part of the Sansure group network of diagnostic companies.
  • First LightcoreOthersSubsidiary company of Sansure operating as part of the Sansure group, focused on specific diagnostic applications.
  • SepsetcoreOthersSubsidiary company of Sansure included in the Sansure group of companies for expanded diagnostic capabilities.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Sansure competitors and assessment

Company assessment

Direct peers

  • Hologic: Direct competitor in women's health molecular diagnostics, including HPV testing (Aptima) and Panther automated systems. Hologic's high-throughput HPV screening reagents compete directly with Sansure's HPV 13+2, 15HR, and G23 genotyping kits.
  • Daan Gene: Chinese IVD company with strong nucleic acid test (NAT) portfolio for HBV, HCV, HIV blood screening, and HPV. Daan Gene is a direct Chinese competitor in blood safety screening and HPV, the same core categories as Sansure.
  • Qiagen: Direct peer in nucleic acid extraction and sample preparation technologies (QIAcube, QIAsymphony), plus molecular diagnostic kits for HPV and infectious diseases. Qiagen's magnetic-bead extraction technology directly competes with Sansure's Advanced Magnetic Beads platform.
  • Autobio Diagnostics: Chinese-domestic IVD company with overlapping products in chemiluminescence immunoassays, microbiology, and molecular diagnostics. Autobio is the most direct Chinese-listed competitor to Sansure's broader diagnostics portfolio.
  • Seegene: Direct competitor in multiplex PCR-based molecular diagnostics, particularly for syndromic infectious disease panels. Seegene's Allplex assays compete with Sansure's multiplex respiratory pathogen and CT/UU/NG reproductive infection kits.
  • Snibe Diagnostics: Shenzhen-headquartered IVD company with chemiluminescence immunoassay and molecular diagnostic products. Snibe is a comparable Chinese IVD peer with international expansion (CE-marked, exported globally) overlapping Sansure's strategy.
  • Cepheid (Danaher): Direct competitor in PCR-based molecular diagnostics, particularly the GeneXpert system for point-of-care and clinical lab nucleic acid testing. Cepheid's cartridge-based PCR platform competes directly with Sansure's iPonatic mPOCT station and Natch extraction systems.

Broad incumbents

  • Roche Diagnostics: Broad incumbent in molecular diagnostics with cobas systems and a comprehensive infectious disease, HPV, and blood screening menu. Roche's entrenched installed base in hospital labs sets the competitive benchmark Sansure seeks to disrupt.
  • Abbott Molecular: Broad incumbent with m2000 and Alinity m systems for molecular diagnostics, covering HPV, HIV, HCV, and HBV. Abbott's global blood bank and clinical lab presence competes with Sansure's C004E blood screening kit and infectious disease portfolio.
  • bioMérieux (BioFire): Broad incumbent with the BioFire FilmArray syndromic PCR panels for respiratory, gastrointestinal, and bloodstream infections. BioFire's point-of-care syndromic testing model overlaps with Sansure's iPonatic mPOCT strategy in decentralized settings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Sansure social profiles

Digital presence

Sansure compliance and trust

Trust signal

Compliance3 records

Sansure financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sansure leadership team

Management profile

Number of profiles

Profiles1 record

Sansure subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Sansure funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sansure M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sansure

What does Sansure do?

Sansure manufactures and sells molecular diagnostic instruments and reagent kits built on PCR and nucleic acid extraction technologies. Its product ecosystem spans automated extraction systems (Natch CS2, Natch CS3 Plus, Natch 48, Natch 16S), the portable iPonatic point-of-care molecular workstation, and a portfolio of 500+ reagent kits for HPV, HBV, HCV, HIV, respiratory pathogens, monkeypox, and reproductive tract infections. Customers are clinical laboratories, hospitals, blood banks, and public health agencies.

Is Sansure a public or private company?

Sansure is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Sansure founded?

Sansure was founded in 2008. It employs 501 to 1,000 people.

Where is Sansure based?

Sansure is headquartered in Changshan, China, in the Asia region.

How does Sansure make money?

Three revenue lines are on record. Diagnostic Reagents are the primary driver. The others are diagnostic Instruments and mPOCT Products.

Who are Sansure's main competitors?

Direct peers on record are Hologic, Daan Gene, Qiagen, Autobio Diagnostics, Seegene, Snibe Diagnostics and Cepheid (Danaher). Broad incumbents are Roche Diagnostics, Abbott Molecular and bioMérieux (BioFire).

Does Sansure have an API?

No public API is recorded for Sansure.

What industry is Sansure in?

Sansure's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGAEAI, Sample Logistics, Biorepository & IVD Kit Management (Trial Support). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals